Nov 10

CFDRC awarded NIH grant on personalized therapy for Cystic Fibrosis

CFD Research Corporation was awarded a grant from the National Institutes of Health (NIH) to develop a predictive model for personalized responses to cystic fibrosis transmembrane conductance regulator (CFTR)-directed therapeutics. The successful outcome of this project will lead to the development and commercialization of a personalized medicine platform for Cystic Fibrosis (CF) patients.

Read full article >

Aug 01

CFD Research awarded battery prototyping SBIR Phase III project

CFD Research announced today that it has been awarded a Small Business Innovation Research (SBIR) Phase III contract through the Aviation and Missile Technology Consortium (AMTC) to perform important battery technology development and prototyping. The three-year Other Transaction Authority (OTA) agreement has a ceiling value of $15.5 million.

Read full article >

May 08

CFD Research work featured in Washington Post Health Science news

The Washington Post published an article about using microbes called extremophiles to combat superbugs and biowarfare agents. Our own AJ Singhal was interviewed and quoted in the article!

Read full article >

May 03

CFD Research Awarded 50M SBIR Phase III Project for Environment Effects

CFD Research Corporation announced today that it has been awarded a Small Business Innovation Research (SBIR) Phase III contract from the U.S. Army Contracting Command, for the development of environment analysis tools, models, and test capabilities to characterize weather environment effects on the performance of weapon systems and sensors.

Read full article >